https://www.selleckchem.com/products/nx-2127.html
Our findings remained robust on carrying out sensitivity analysis with the oral anti-diabetics market as a control. Post-intervention, the average monthly difference between antimicrobials under Schedule H1 and the control group witnessed an immediate increase of 16.3% ( = 0.1 followed by a sustained reduction of 0.5% ( = 0.13) compared with the pre-intervention scenario. Though the regulation had a positive impact in terms of reducing sales of antimicrobials notified under the regulation, optimizing the effectiveness of such stand-al
Like
Comment
Share
